Automated GPCR Signaling Studies in 1536-well Format Using the Non-Lytic Live-Cell...
Automated GPCR Signaling Studies in 1536-well Format Using the Non-Lytic Live-Cell GloSensor cAMP Assay Scientific Poster
Sarah Shultz1, Pete Stecha1, Brock Binkowski1, Jean Shieh2, Howard Lee2 and Edward J. Dell3
1Promega Corporation, Madison, WI USA
2Labcyte Incorporated, Sunnyvale, CA USA
3BMG LABTECH, Durham, NC USA
GPCRs play an important role in a variety of biological processes, including immune system activity and behavior regulation. GPCRs are popular targets in drug discovery research and a well-designed assay can help expedite the discovery of novel candidates. Many pharmaceutical high-throughput screening (HTS) programs desire a simple, sensitive, automatable GPCR-specific cell-based assay with a wide dynamic range and low susceptibility to compound interference. In this poster we present the new Promega GloSensor™ cAMP Assay, an HTS-friendly bioluminescent assay capable of measuring intracellular cAMP levels in living cells in real-time. Two HTS instruments are used for dispensing components of this application to screen for effects on GPCRs. Specifically, ultra low volumes of compounds are dispensed into 1536-well assay plates using the Labcyte® Echo® 555 acoustic liquid handler, and GloSensor™ cAMP cells are dispensed using the Deerac HTS reagent dispense. Implementing a miniaturized GPCR assay as demonstrated in this poster allows cost-effective screening for modulators of GPCR function, a useful tool for labs in the pharmaceutical HTS industry.
- Part# PS080
- Printed in USA.